Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eric A Rose Insider Profile
4 Followers
Eric A Rose, Director at Keryx Biopharma, holds 0.00 shares in Keryx Biopharma (Ticker: KERX), holds 411.62K shares in Mesoblast Limited (Ticker: MEOBF). Most recently, Eric A Rose ― shares of Keryx Biopharma on ― for an estimated value of ―.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+2.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Medical Officer
Roles that Eric A Rose holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric A Rose
Eric A Rose's Trading History
Keryx Biopharma
―
―
―
$0.00
Mesoblast Limited
May 10, 2024
Chief Medical Officer
Informative Buy
151.20K
$309.95K
List of latest transactions for each holding click on a transaction to see Eric A Rose's performance on stock
You May Also Like
Eric A Rose insider profile FAQ
What is the percentage of profitable transactions made by Eric A Rose?
The percentage of profitable transactions made by Eric A Rose is 100%.
What is the average return per transaction made by Eric A Rose?
The average return per transaction made by Eric A Rose is 2.00%.
What stocks does Eric A Rose hold?
Eric A Rose holds: KERX, MEOBF stocks.
What was Eric A Rose’s latest transaction?
Eric A Rose latest transaction was an Uninformative Buy of ―.
What was Eric A Rose's most profitable transaction?
Eric A Rose’s most profitable transaction was an Informative Buy of MEOBF stock on May 10, 2024. The return on the trade was 3.10%.
What is Eric A Rose's role in Keryx Biopharma?
Eric A Rose's role in Keryx Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.